Stage changes · close of Sep 16, 2026
Stocks that entered Stage 2 on Sep 16, 2026
10 entered Stage 2, 22 entered Stage 4, 28 entered Stage 3 and 7 entered Stage 1, among US stocks above our tradable floor ($5 and $1 million a day). Each row is that day's close, largest companies first.
From a base into Stage 2 (10)
A new advance: the stock left its base and its trend turned up.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| TEMTempus AI | Health Care | $69.97 | +1.6% | -32.2% | 38 | Stage 1 | $12.6B |
| QGENQiagen | Health Care | $42.90 | +1.0% | -22.2% | 48 | Stage 1 | $8.9B |
| ICLICL Group | Materials | $5.48 | -1.8% | -18.2% | 45 | Stage 1 | $7.1B |
| EXLSExlService Holdings | Information Technology | $35.85 | -1.2% | -18.6% | 39 | Stage 1 | $5.4B |
| EXPOExponent | Industrials | $68.01 | +1.0% | -13.6% | 51 | Stage 1 | $3.2B |
| BHCBausch Health Companies | Health Care | $5.69 | +0.4% | -28.0% | 36 | Stage 1 | $2.1B |
| ALVOAlvotech | Health Care | $5.10 | +1.6% | -43.2% | 26 | Stage 1 | $1.8B |
| GDYNGrid Dynamics Holdings | Information Technology | $8.02 | -1.4% | -20.3% | 57 | Stage 1 | $651M |
| IIIInformation Services Group | Information Technology | $5.27 | -2.0% | -10.9% | 53 | Stage 1 | $255M |
| CAICaris Life Sciences | Health Care | $28.21 | -1.0% | -16.2% | 40 | Stage 1 | — |
Into Stage 4 (22)
A decline began: the stock broke down below its trend.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| SYKStryker | Health Care | $283.86 | +1.2% | -26.1% | 34 | Stage 1 | $109B |
| ORLYO'Reilly Automotive | Consumer Discretionary | $83.68 | -1.7% | -22.4% | 35 | Stage 1 | $67.7B |
| NXPINXP Semiconductors | Information Technology | $218.98 | -2.8% | -33.7% | 53 | Stage 3 | $55.2B |
| IRIngersoll Rand | Industrials | $71.44 | -0.7% | -27.6% | 44 | Stage 1 | $27.7B |
| OTISOtis Worldwide | Industrials | $69.25 | +1.1% | -25.1% | 35 | Stage 1 | $26.4B |
| CNPCenterPoint Energy, Inc (Holding Co) | Utilities | $38.33 | +0.9% | -14.4% | 53 | Stage 3 | $25.2B |
| COOCooper Companies | Health Care | $54.61 | +2.5% | -35.2% | 39 | Stage 1 | $10.4B |
| NHINational Health Investors | Real Estate | $67.20 | -1.6% | -23.4% | 44 | Stage 1 | $3.3B |
| MZTIMarzetti | Consumer Staples | $102.96 | +1.6% | -41.5% | 24 | Stage 1 | $2.8B |
| BKDBrookdale Senior Living | Health Care | $11.67 | -1.5% | -30.4% | 85 | Stage 3 | $2.8B |
| PRVAPrivia Health Group | Health Care | $20.37 | 0.0% | -27.5% | 45 | Stage 3 | $2.6B |
| GPCRStructure Therapeutics | Health Care | $35.50 | -8.9% | -62.1% | 90 | Stage 1 | $2.5B |
| UAAUnder Armour | Consumer Discretionary | $5.00 | +0.8% | -38.6% | 54 | Stage 3 | $2.1B |
| INODInnodata | Information Technology | $55.41 | +1.9% | -54.4% | 40 | Stage 3 | $1.9B |
| SAMBoston Beer | Consumer Staples | $170.25 | -0.6% | -34.5% | 36 | Stage 1 | $1.8B |
| NSSCNAPCO Security Technologies | Industrials | $36.33 | +1.1% | -22.1% | 40 | Stage 1 | $1.3B |
| RAREUltragenyx Pharmaceutical | Health Care | $12.88 | -1.5% | -64.8% | 18 | Stage 3 | $1.3B |
| OLMAOlema Pharmaceuticals | Health Care | $9.73 | -0.5% | -72.8% | 69 | Stage 1 | $851M |
| APEIAmerican Public Education | Consumer Staples | $44.44 | -0.7% | -27.0% | 72 | Stage 3 | $813M |
| KYTXKyverna Therapeutics | Health Care | $6.90 | -0.9% | -38.7% | 90 | Stage 1 | $427M |
| OFIXOrthofix Medical | Health Care | $8.90 | -2.1% | -45.2% | 25 | Stage 1 | $363M |
| RFILRF Industries | Industrials | $8.20 | -0.1% | -61.9% | 64 | Stage 3 | $89.0M |
Into Stage 3 (28)
The advance stalled and the stock started to move sideways near its high.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| MSMorgan Stanley | Financials | $202.42 | -1.9% | -10.9% | 75 | Stage 2 | $318B |
| AXPAmerican Express | Financials | $311.47 | -3.7% | -18.2% | 49 | Stage 2 | $211B |
| SNASnap-On | Industrials | $372.98 | -0.5% | -10.5% | 62 | Stage 2 | $19.3B |
| NNNNNN REIT | Real Estate | $41.65 | -3.6% | -14.9% | 54 | Stage 2 | $7.9B |
| ALKSAlkermes | Health Care | $46.07 | +0.1% | -16.6% | 89 | Stage 2 | $7.7B |
| IFSIntercorp Financial Services | Financials | $54.77 | +1.0% | -9.7% | 78 | Stage 2 | $6.1B |
| COGTCogent Biosciences | Health Care | $32.54 | -0.6% | -24.0% | 96 | Stage 2 | $5.6B |
| XMTRXometry | Industrials | $93.15 | +6.4% | -11.2% | 90 | Stage 2 | $5.3B |
| VSECVSE | Industrials | $184.69 | +3.8% | -24.1% | 61 | Stage 2 | $5.2B |
| DORMDorman Products | Consumer Discretionary | $124.96 | -0.2% | -21.4% | 34 | Stage 2 | $3.7B |
| BANFBancFirst | Financials | $109.09 | -1.2% | -17.6% | 39 | Stage 2 | $3.7B |
| MHOM/I Homes | Consumer Discretionary | $140.48 | -1.3% | -13.8% | 46 | Stage 2 | $3.6B |
| CALMCal-Maine Foods | Consumer Staples | $74.29 | -0.1% | -26.8% | 31 | Stage 2 | $3.5B |
| VKTXViking Therapeutics | Health Care | $29.52 | -1.4% | -29.9% | 70 | Stage 2 | $3.4B |
| DNLIDenali Therapeutics | Health Care | $20.06 | -1.6% | -26.3% | 84 | Stage 2 | $3.2B |
| AMBAAmbarella | Information Technology | $62.77 | -2.4% | -34.3% | 35 | Stage 2 | $2.8B |
| VCELVericel | Health Care | $40.21 | +1.2% | -16.8% | 73 | Stage 2 | $2.1B |
| PEBPebblebrook Hotel Trust | Real Estate | $17.83 | -1.9% | -9.7% | 85 | Stage 2 | $2.0B |
| AGIOAgios Pharmaceuticals | Health Care | $32.95 | +0.4% | -27.6% | 44 | Stage 2 | $2.0B |
| GTYGetty Realty | Real Estate | $29.58 | -4.3% | -17.8% | 63 | Stage 2 | $1.9B |
| UVSPUnivest Financial | Financials | $42.68 | -0.1% | -5.1% | 81 | Stage 2 | $1.2B |
| PGCPeapack-Gladstone Financial | Financials | $45.03 | -1.5% | -6.7% | 85 | Stage 2 | $798M |
| NRIMNorthrim BanCorp | Financials | $25.56 | -1.7% | -12.4% | 65 | Stage 2 | $569M |
| RGNXREGENXBIO | Health Care | $7.98 | +0.4% | -50.1% | 42 | Stage 2 | $527M |
| OLPOne Liberty Properties | Real Estate | $22.41 | -0.8% | -10.1% | 58 | Stage 2 | $501M |
| RELLRichardson Electronics | Information Technology | $16.45 | +1.0% | -24.4% | 88 | Stage 2 | $245M |
| LOVELovesac | Consumer Discretionary | $14.63 | -2.1% | -21.8% | 38 | Stage 2 | $211M |
| IMUXImmunic | Health Care | $10.12 | -2.4% | -40.1% | 75 | Stage 2 | — |
Into Stage 1 (7)
A decline ended and the stock started to base.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| WMGWarner Music Group | Communication Services | $28.30 | -2.6% | -17.5% | 42 | Stage 4 | $14.8B |
| CLFCleveland-Cliffs | Materials | $12.15 | +3.1% | -24.9% | 53 | Stage 4 | $6.9B |
| ALMAlmonty Industries | Materials | $13.47 | -4.1% | -42.5% | 97 | Stage 2 | $3.9B |
| MMSMaximus | Industrials | $57.61 | -1.0% | -40.8% | 28 | Stage 4 | $3.0B |
| CMRECostamare | Industrials | $14.91 | -0.6% | -14.7% | 69 | Stage 4 | $1.8B |
| XPELXPEL | Consumer Discretionary | $45.74 | -0.7% | -16.8% | 76 | Stage 2 | $1.3B |
| CRESYCresud S.A.C.I.F. y A. | Industrials | $12.02 | +1.0% | -14.8% | 84 | Stage 4 | $853M |
Stage changes come from our stage analysis of each stock after the close; a change can reverse in the following sessions. Nothing here is investment advice.